These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187 [TBL] [Abstract][Full Text] [Related]
25. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice. Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396 [TBL] [Abstract][Full Text] [Related]
26. Interferon-γ constrains cytokine production of group 2 innate lymphoid cells. Kudo F; Ikutani M; Seki Y; Otsubo T; Kawamura YI; Dohi T; Oshima K; Hattori M; Nakae S; Takatsu K; Takaki S Immunology; 2016 Jan; 147(1):21-9. PubMed ID: 26425820 [TBL] [Abstract][Full Text] [Related]
28. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation. Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH Front Immunol; 2021; 12():664218. PubMed ID: 34867937 [TBL] [Abstract][Full Text] [Related]
29. Lung ILC2s link innate and adaptive responses in allergic inflammation. Martinez-Gonzalez I; Steer CA; Takei F Trends Immunol; 2015 Mar; 36(3):189-95. PubMed ID: 25704560 [TBL] [Abstract][Full Text] [Related]
30. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation. Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554 [TBL] [Abstract][Full Text] [Related]
31. Exogenous oxidative stress suppresses IL-33 -driven proliferation programming in group 2 innate lymphoid cells. Zheng C; Lu Z; Wu H; Cui L; Bi J; Wan X Int Immunopharmacol; 2021 Jun; 95():107541. PubMed ID: 33756232 [TBL] [Abstract][Full Text] [Related]
32. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation. Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126 [TBL] [Abstract][Full Text] [Related]
33. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis. Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q Front Immunol; 2021; 12():670676. PubMed ID: 33995408 [TBL] [Abstract][Full Text] [Related]
36. Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight. Andreone S; Gambardella AR; Mancini J; Loffredo S; Marcella S; La Sorsa V; Varricchi G; Schiavoni G; Mattei F Front Immunol; 2020; 11():571593. PubMed ID: 33329534 [TBL] [Abstract][Full Text] [Related]
37. Dendritic cell-induced activation of adaptive and innate antitumor immunity. van den Broeke LT; Daschbach E; Thomas EK; Andringa G; Berzofsky JA J Immunol; 2003 Dec; 171(11):5842-52. PubMed ID: 14634094 [TBL] [Abstract][Full Text] [Related]
38. Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Moro K; Kabata H; Tanabe M; Koga S; Takeno N; Mochizuki M; Fukunaga K; Asano K; Betsuyaku T; Koyasu S Nat Immunol; 2016 Jan; 17(1):76-86. PubMed ID: 26595888 [TBL] [Abstract][Full Text] [Related]
39. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1. Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300 [TBL] [Abstract][Full Text] [Related]
40. Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice. KleinJan A; Klein Wolterink RG; Levani Y; de Bruijn MJ; Hoogsteden HC; van Nimwegen M; Hendriks RW J Immunol; 2014 Feb; 192(4):1385-94. PubMed ID: 24415780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]